Injective (INJ) has been making strides, breaking above the $24.27 resistance level and climbing towards the $27.5 mark. This positive movement alig
Injective (INJ) has been making strides, breaking above the $24.27 resistance level and climbing towards the $27.5 mark. This positive movement aligns with the recent Bitcoin rally, which saw the cryptocurrency surge from $57.3k to $67.6k.
However, INJ’s upward trajectory is facing challenges. The token is currently trading below the 50% Fibonacci level resistance at $29.6, and it’s encountering resistance at the $28.2 mark within a descending channel that has been in place since early April.
Bullish Signals Amidst Resistance
While the descending channel poses a hurdle, there are positive indicators suggesting potential bullish momentum. The recent breakout above $24.27 has flipped the market structure bullishly, and the OBV indicator, though in a downtrend, shows signs of accumulation.
Additionally, the 30-day MVRV ratio indicates short-term holders have amassed significant profits, which could potentially lead to a selling wave. However, the rising mean coin age and low dormant circulation suggest ongoing network-wide accumulation.
Cautious Optimism
Despite these bullish signals, it’s essential to remain cautious. The weakening short-term sentiment and demand, coupled with a slowdown in Open Interest and spot CVD, hint at a potential pullback.
The $24.18 level and the mid-channel mark at $21.5-$22 are crucial support zones if the price is rejected from the current resistance levels.
Injective’s Institutional Boost
In other news, Injective has made a significant stride by launching AINJ, the Injective Staking Exchange Traded Product (ETP). This move is expected to attract substantial institutional investment, providing a bridge between traditional finance and the decentralized world of Injective.
The launch of AINJ positions Injective as a leader in the crypto market, offering investors exposure to INJ and staking rewards through traditional financial channels.
While the immediate price action of INJ faces challenges, the long-term outlook remains promising, especially with the influx of institutional capital through AINJ.
www.fxleaders.com